Clinical Trials Sponsored by Allogene Therapeutics

Total 5 results

  • NCT03939026
    Active, not recruiting
    Conditions: Relapsed/Refractory Large B Cell Lymphoma, Relapsed/Refractory Follicular Lymphoma
  • NCT04416984
    Recruiting
    Conditions: Relapsed/Refractory Large B Cell Lymphoma
  • NCT04696731
    Recruiting
    Conditions: Advanced/Metastatic Clear Cell Renal Cell Carcinoma
  • NCT04093596
    Recruiting
    Conditions: Relapsed/Refractory Multiple Myeloma
  • NCT05000450
    Recruiting
    Conditions: Relapsed/Refractory Multiple Myeloma